FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kazuhiko Arima

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Remission Induction

Co-author Network

Publications

TOP 3
Junko Kita; Tomohiro Koga; Hideki Nakamura; Yoshikazu Nakashima; Akitomo Okada; Tomoki Origuchi; Takahisa Suzuki; Mami Tamai; Masataka Uetani; Satoshi Yamasaki; Kiyoshi Aoyagi; Kazuhiko Arima; Katsumi Eguchi; Yoshiro Horai; Hiroaki Ida; Naoki Iwamoto; Shin-ya Kawashiri; Atsushi Kawakami
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Satoshi Miuma; Hisamitsu Miyaaki; Toru Muraoka; Motohisa Akiyama; Kazuhiko Arima; Tatsuki Ichikawa; Toshihisa Matsuzaki; Masashi Ootani; Eisuke Ozawa; Hidetaka Shibata; Fuminao Takeshima; Shigeyuki Takeshita; Naota Taura; Kazuhiko Nakao
Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
Atsushi Kawakami; Kiyoshi Migita; Koh-ichiro Yoshiura; Kazuhiko Arima; Hiroaki Ida; Katsumi Eguchi
[109th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 14. Autoinflammatory syndrome].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kazuhiko Arima (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Junko Kita; Tomohiro Koga; Hideki Nakamura; Yoshikazu Nakashima; Akitomo Okada; Tomoki Origuchi; Takahisa Suzuki; Mami Tamai; Masataka Uetani; Satoshi Yamasaki; Kiyoshi Aoyagi; Kazuhiko Arima; Katsumi Eguchi; Yoshiro Horai; Hiroaki Ida; Naoki Iwamoto; Shin-ya Kawashiri; Atsushi Kawakami
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Modern rheumatology / the Japan Rheumatism Association 2013;23(2):254-9.
2012: Satoshi Miuma; Hisamitsu Miyaaki; Toru Muraoka; Motohisa Akiyama; Kazuhiko Arima; Tatsuki Ichikawa; Toshihisa Matsuzaki; Masashi Ootani; Eisuke Ozawa; Hidetaka Shibata; Fuminao Takeshima; Shigeyuki Takeshita; Naota Taura; Kazuhiko Nakao
Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
Journal of cellular biochemistry 2012;113(10):3113-21.
2012: Atsushi Kawakami; Kiyoshi Migita; Koh-ichiro Yoshiura; Kazuhiko Arima; Hiroaki Ida; Katsumi Eguchi
[109th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 14. Autoinflammatory syndrome].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2012;101(9):2733-9.
2012: Mami Tamai; Masataka Uetani; Kiyoshi Aoyagi; Toshiyuki Aramaki; Kazuhiko Arima; Keita Fujikawa; Aya Fukushima; Hiroaki Ida; Naoki Iwamoto; Makoto Kamachi; Atsushi Kawakami; Hideki Nakamura; Tomoki Origuchi; Katsumi Eguchi
Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings.
Modern rheumatology / the Japan Rheumatism Association 2012;22(5):654-8.
2012: Tomoki Origuchi; Mami Tamai; Kaoru Terada; Toshiaki Tsukada; Yukitaka Ueki; Satoshi Yamasaki; Shin-Ya Kawashiri; Taiichiro Miyashita; Hideki Nakamura; Toshiyuki Aramaki; Kazuhiko Arima; Katsumi Eguchi; Takaaki Fukuda; Masako Furuyama; Nozomi Iwanaga; Yojiro Kawabe; Atsushi Kawakami
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome.
Modern rheumatology / the Japan Rheumatism Association 2012;22(4):584-8.
2012: Tomohiro Koga; Shigeru Kohno; Masataka Kuwana; Hiroshi Mukae; Hideki Nakamura; Yoshikazu Nakashima; Akitomo Okada; Tomoki Origuchi; Takahisa Suzuki; Mami Tamai; Satoshi Yamasaki; Kiyoshi Aoyagi; Kazuhiko Arima; Katsumi Eguchi; Keita Fujikawa; Manabu Fujimoto; Yasuhito Hamaguchi; Yoshiro Horai; Yuji Ishimatsu; Naoki Iwamoto; Shin-Ya Kawashiri; Atsushi Kawakami
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
Rheumatology (Oxford, England) 2012;51(7):1278-84.
2012: Junko Kita; Tomohiro Koga; Hideki Nakamura; Yoshikazu Nakashima; Akitomo Okada; Tomoki Origuchi; Takahisa Suzuki; Mami Tamai; Masataka Uetani; Satoshi Yamasaki; Kiyoshi Aoyagi; Kazuhiko Arima; Katsumi Eguchi; Hiroaki Ida; Naoki Iwamoto; Shin-Ya Kawashiri; Atsushi Kawakami
Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration.
Modern rheumatology / the Japan Rheumatism Association 2012;22(3):346-52.
2012: Junko Kita; Tomohiro Koga; Hideki Nakamura; Munetoshi Nakashima; Yoshikazu Nakashima; Akitomo Okada; Tomoki Origuchi; Takahisa Suzuki; Mami Tamai; Toshiaki Tsukada; Masataka Uetani; Satoshi Yamasaki; Kiyoshi Aoyagi; Toshiyuki Aramaki; Kazuhiko Arima; Katsumi Eguchi; Keita Fujikawa; Hiroaki Ida; Shin-ya Kawashiri; Atsushi Kawakami
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Modern rheumatology / the Japan Rheumatism Association 2012;22(2):195-201.
2012: Kunihiro Ichinose; Hiroaki Ida; Naoki Iwamoto; Makoto Kamachi; Atsushi Kawakami; Shin-ya Kawashiri; Hideki Nakamura; Tomoki Origuchi; Mami Tamai; Toshiyuki Aramaki; Kazuhiko Arima; Keita Fujikawa; Katsumi Eguchi
Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases.
Rheumatology international 2012;32(2):483-7.
2011: Kazuhiko Arima; Katsumi Eguchi; Fukumi Furukawa; Makito Hirano; Kunihiro Ichinose; Hiroaki Ida; Nobuo Kanazawa; Takeumi Kaneko; Shimpei Kasagi; Atsushi Kawakami; Seiji Kawano; Akira Kinoshita; Shunichi Kumagai; Masahiro Matsunaka; Tsuneyo Mimori; Hiroyuki Mishima; Tsunehiro Mizushima; Shigeo Murata; Hideki Nakamura; Norio Niikawa; Koichiro Ohmura; Hirotoshi Sugino; Keiji Tanaka; Keiko Tanaka; Masami Tanaka; Itaru Toyoshima; Akira Tsujino; Satoshi Ueno; Akio Yamakawa; Koh-ichiro Yoshiura
Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(36):14914-9.
2011: Tomoki Origuchi; Mami Tamai; Yukitaka Ueki; Satoshi Yamasaki; Toshiyuki Aramaki; Kazuhiko Arima; Keita Fujikawa; Takaaki Fukuda; Hiroaki Ida; Naoki Iwamoto; Yojiro Kawabe; Atsushi Kawakami; Shin-ya Kawashiri; Naoki Matsuoka; Masanobu Mine; Akinari Mizokami; Hideki Nakamura; Munetoshi Nakashima; Katsumi Eguchi
Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor.
Modern rheumatology / the Japan Rheumatism Association 2011;21(3):244-50.
2011: Naoki Iwamoto; Makoto Kamachi; Atsushi Kawakami; Shin-ya Kawashiri; Junko Kita; Tomohiro Koga; Hideki Nakamura; Akitomo Okada; Tomoki Origuchi; Mami Tamai; Satoshi Yamasaki; Kazuhiko Arima; K Ichinose; Hiroaki Ida; Katsumi Eguchi
Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.
Modern rheumatology / the Japan Rheumatism Association 2011;21(3):240-3.
2011: Mami Tamai; Masataka Uetani; Satoshi Yamasaki; Kiyoshi Aoyagi; Toshiyuki Aramaki; Kazuhiko Arima; Keita Fujikawa; Hiroaki Ida; Naoki Iwamoto; Makoto Kamachi; Atsushi Kawakami; Shin-Ya Kawashiri; Junko Kita; Tomohiro Koga; Hideki Nakamura; Akitomo Okada; Tomoki Origuchi; Shoichiro Takao; Katsumi Eguchi
Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by magnetic resonance imaging of the wrist and finger joints and physical examination.
Arthritis care & research 2011;63(3):436-9.
2010: Satoru Akazawa; K Ichinose; Tomoki Origuchi; Shin-ya Kawashiri; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Makoto Kamachi; Kazuhiko Arima; Mami Tamai; Hideki Nakamura; Hiroaki Ida; Atsushi Kawakami; Katsumi Eguchi
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine.
Modern rheumatology / the Japan Rheumatism Association 2010;20(6):606-10.
2010: Naoki Iwamoto; Atsushi Kawakami; Kazuhiko Arima; Hideki Nakamura; Shin-ya Kawashiri; Mami Tamai; Junko Kita; Akitomo Okada; Tomohiro Koga; Makoto Kamachi; Satoshi Yamasaki; Kunihiro Ichinose; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sjögren's syndrome by monocyte chemotactic protein-1.
Rheumatology (Oxford, England) 2010;49(8):1472-8.
2010: Keita Fujikawa; Atsushi Kawakami; Tomayoshi Hayashi; Naoki Iwamoto; Shin-ya Kawashiri; Toshiyuki Aramaki; K Ichinose; Mami Tamai; Kazuhiko Arima; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
Modern rheumatology / the Japan Rheumatism Association 2010;20(1):86-9.
2010: Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Kazuhiko Arima; K Ichinose; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Katsumi Eguchi
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.
Modern rheumatology / the Japan Rheumatism Association 2010;20(1):40-5.
2010: Kunihiro Ichinose; Tomoki Origuchi; Shin-ya Kawashiri; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Makoto Kamachi; Kazuhiko Arima; Mami Tamai; Hideki Nakamura; Hiroaki Ida; Atsushi Kawakami; Toshiaki Tsukada; Yukitaka Ueki; Katsumi Eguchi
Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis.
Internal medicine (Tokyo, Japan) 2010;49(20):2211-8.
2009: Shin-Ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Kazuhiko Arima; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Toshiyuki Tsurumoto; Masafumi Kono; Hiroyuki Shindo; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
The Journal of rheumatology 2009;36(11):2397-402.
2009: Hiroaki Ida; Toshiyuki Aramaki; Hideki Nakamura; Keita Fujikawa; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Katsuya Satoh; Tomoki Origuchi; Atsushi Kawakami; I Furuichi; Yojiro Kawabe; Katsumi Eguchi
Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis.
Cytotechnology 2009;60(1-3):161-4.
2009: Mami Tamai; Atsushi Kawakami; Masataka Uetani; Shoichiro Takao; Kazuhiko Arima; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Shin-Ya Kawashiri; Kunihiro Ichinose; Makoto Kamachi; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Kiyoshi Aoyagi; Katsumi Eguchi
A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.
Arthritis and rheumatism 2009;61(6):772-8.
2009: Shinya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Kunihiro Ichinose; Makoto Kamachi; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Masako Kita; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
[A case of microscopic polyangiitis relapsed with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2009;32(3):189-94.
2009: Keita Fujikawa; Atsushi Kawakami; Mami Tamai; Masataka Uetani; Shoichiro Takao; Kazuhiko Arima; Naoki Iwamoto; Toshiyuki Aramaki; Shinya Kawashiri; Kunihiro Ichinose; Makoto Kamachi; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Kiyoshi Aoyagi; Katsumi Eguchi
High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
The Journal of rheumatology 2009;36(6):1126-9.
2009: Toshiyuki Aramaki; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Shin-ya Kawashiri; Mami Tamai; Kazuhiko Arima; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Munetoshi Nakashima; Akinari Mizokami; Masako Furuyama; Naoki Matsuoka; Yukitaka Ueki; Hiroaki Ida; Tomoki Origuchi; Kiyoshi Aoyagi; Katsumi Eguchi
Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables.
Modern rheumatology / the Japan Rheumatism Association 2009;19(6):652-6.
2009: Naoki Iwamoto; Atsushi Kawakami; Keita Fujikawa; Toshiyuki Aramaki; Shin-Ya Kawashiri; Mami Tamai; Kazuhiko Arima; Kunihiro Ichinose; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Munetoshi Nakashima; Akinari Mizokami; Akiko Goto; Takaaki Fukuda; Naoki Matsuoka; Yukitaka Ueki; Toshiaki Tsukada; Kiyoshi Migita; Fumiko Shoumura; Yojiro Kawabe; Kazutaka Shibatomi; Masanobu Mine; Hiroaki Ida; Tomoki Origuchi; Kiyoshi Aoyagi; Katsumi Eguchi
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.
Modern rheumatology / the Japan Rheumatism Association 2009;19(5):488-92.
2009: Toshiyuki Aramaki; Hiroaki Ida; Yasumori Izumi; Keita Fujikawa; Mingguo Huang; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Hideki Nakamura; Atsushi Kawakami; Tomoki Origuchi; Naoki Matsuoka; Katsumi Eguchi
A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis.
Modern rheumatology / the Japan Rheumatism Association 2009;19(3):245-52.
2009: Naoki Iwamoto; Atsushi Kawakami; Mami Tamai; Keita Fujikawa; Kazuhiko Arima; Toshiyuki Aramaki; Shinya Kawashiri; Kunihiro Ichinose; Makoto Kamachi; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Katsumi Eguchi
Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
The Journal of rheumatology 2009;36(1):113-5.
2007: Mami Tamai; Atsushi Kawakami; Masataka Uetani; Shoichiro Takao; Fumiko Tanaka; Keita Fujikawa; Toshiyuki Aramaki; Hideki Nakamura; Nozomi Iwanaga; Yasumori Izumi; Kazuhiko Arima; Kouichiro Aratake; Makoto Kamachi; Mingguo Huang; Tomoki Origuchi; Hiroaki Ida; Kiyoshi Aoyagi; Katsumi Eguchi
Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis.
The Journal of rheumatology 2007;34(11):2154-7.
2007: Mingguo Huang; Hiroaki Ida; Kazuhiko Arima; Hideki Nakamura; Toshiyuki Aramaki; Keita Fujikawa; Mami Tamai; Makoto Kamachi; Atsushi Kawakami; Hironori Yamasaki; Tomoki Origuchi; Katsumi Eguchi
La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity.
Life sciences 2007;81(19-20):1461-6.
2007: Atsushi Kawakami; Koto Nakashima; Mami Tamai; Hideki Nakamura; Nozomi Iwanaga; Keita Fujikawa; Toshiyuki Aramaki; Kazuhiko Arima; Naoki Iwamoto; Kunihiro Ichinose; Makoto Kamachi; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.
The Journal of rheumatology 2007;34(5):1019-26.
2007: Nozomi Iwanaga; Makoto Kamachi; Keita Fujikawa; Toshiyuki Aramaki; Yasumori Izumi; Kazuhiko Arima; Mami Tamai; Kouichiro Aratake; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Atsushi Kawakami; Takashi Taguchi; Katsumi Eguchi
Membraneous glomerulonephritis and non-Hodgkin's lymphoma in a patient with primary Sjögren's syndrome.
Internal medicine (Tokyo, Japan) 2007;46(4):191-4.
2007: K Fujikawa; Kouichiro Aratake; Atsushi Kawakami; T Aramaki; Nozomi Iwanaga; Y Izumi; Kazuhiko Arima; Makoto Kamachi; Mami Tamai; M Huang; H Nakamura; Y Nishiura; Tomoki Origuchi; Hiroaki Ida; K Eguchi
Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Annals of the rheumatic diseases 2007;66(1):136-7.
2006: Yasumori Izumi; Hiroaki Ida; Mingguo Huang; Nozomi Iwanaga; Fumiko Tanaka; Kouichiro Aratake; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami; Paul Anderson; Katsumi Eguchi
Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
The Journal of laboratory and clinical medicine 2006;147(5):242-9.
2006: Mami Tamai; Atsushi Kawakami; Fumiko Tanaka; Taiichiro Miyashita; Hideki Nakamura; Nozomi Iwanaga; Yasumori Izumi; Kazuhiko Arima; Kouichiro Aratake; Mingguo Huang; Makoto Kamachi; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Significant inhibition of TRAIL-mediated fibroblast-like synovial cell apoptosis by IFN-gamma through JAK/STAT pathway by translational regulation.
The Journal of laboratory and clinical medicine 2006;147(4):182-90.
2006: Mami Tamai; Atsushi Kawakami; Nozomi Iwanaga; Keita Fujikawa; Fumiko Tanaka; Toshiyuki Aramaki; Yasumori Izumi; Kouichiro Aratake; Kazuhiko Arima; Makoto Kamachi; Hideki Nakamura; Mingguo Huang; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Examination of IgM rheumatoid factor (IgM-RF) and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) in Japanese patients with palindromic rheumatism.
Internal medicine (Tokyo, Japan) 2006;45(12):795-7.
2006: Yasumori Izumi; Masahiro Tominaga; Nozomi Iwanaga; Mingguo Huang; Fumiko Tanaka; Kouichiro Aratake; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Hideki Nakamura; Hiroaki Ida; Tomoki Origuchi; Atsushi Kawakami; Katsumi Eguchi
Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis.
Modern rheumatology / the Japan Rheumatism Association 2006;16(1):20-3.
2006: Fumiko Tanaka; Atsushi Kawakami; Nozomi Iwanaga; Mami Tamai; Yasumori Izumi; Kouichiro Aratake; Kazuhiko Arima; Makoto Kamachi; Hideki Nakamura; Mingguo Huang; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
Internal medicine (Tokyo, Japan) 2006;45(5):313-6.
2006: Mami Tamai; Atsushi Kawakami; Masataka Uetani; S Takao; H Rashid; F Tanaka; K Fujikawa; T Aramaki; H Nakamura; Nozomi Iwanaga; Y Izumi; Kazuhiko Arima; Kouichiro Aratake; Makoto Kamachi; M Huang; Tomoki Origuchi; Hiroaki Ida; K Aoyagi; K Eguchi
Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination.
Annals of the rheumatic diseases 2006;65(1):134-5.
2006: Mami Tamai; Atsushi Kawakami; Masataka Uetani; S Takao; F Tanaka; H Nakamura; Nozomi Iwanaga; Y Izumi; Kazuhiko Arima; Kouichiro Aratake; Makoto Kamachi; M Huang; Tomoki Origuchi; Hiroaki Ida; K Aoyagi; K Eguchi
The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(1):133-4.
2005: Kazuhiko Arima; Tomoki Origuchi; Mami Tamai; Nozomi Iwanaga; Y Izumi; M Huang; F Tanaka; Makoto Kamachi; Kouichiro Aratake; Hideki Nakamura; Hiroaki Ida; Masataka Uetani; Atsushi Kawakami; Katsumi Eguchi
RS3PE syndrome presenting as vascular endothelial growth factor associated disorder.
Annals of the rheumatic diseases 2005;64(11):1653-5.
2005: Mingguo Huang; Hiroaki Ida; Makoto Kamachi; Nozomi Iwanaga; Yasumori Izumi; Fumiko Tanaka; Kouichiro Aratake; Kazuhiko Arima; Mami Tamai; Ayumi Hida; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami; N Ogawa; S Sugai; Paul J Utz; Katsumi Eguchi
Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.
Clinical and experimental immunology 2005;142(1):148-54.
2005: Kouichiro Aratake; Makoto Kamachi; Nozomi Iwanaga; Eiji Kawasaki; Yasumori Izumi; Hiroaki Ida; Fumiko Tanaka; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami; Katsumi Eguchi
A cross-talk between RNA splicing and signaling pathway alters Fas gene expression at post-transcriptional level: alternative splicing of Fas mRNA in the leukemic U937 cells.
The Journal of laboratory and clinical medicine 2005;146(3):184-91.
2005: Fumiko Tanaka; Atsushi Kawakami; Mami Tamai; Hideki Nakamura; Nozomi Iwanaga; Yasumori Izumi; Kazuhiko Arima; Kouichiro Aratake; Mingguo Huang; Makoto Kamachi; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
International journal of molecular medicine 2005;15(5):833-9.
2005: Nozomi Iwanaga; Makoto Kamachi; Kouichiro Aratake; Yasumori Izumi; Hiroaki Ida; Fumiko Tanaka; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami; Katsumi Eguchi
Regulation of alternative splicing of caspase-2 through an intracellular signaling pathway in response to pro-apoptotic stimuli.
The Journal of laboratory and clinical medicine 2005;145(2):105-10.
2003: Taiichiro Miyashita; Atsushi Kawakami; Mami Tamai; Yasumori Izumi; Huang Mingguo; Fumiko Tanaka; Seigo Abiru; Koto Nakashima; Nozomi Iwanaga; Kouichiro Aratake; Makoto Kamachi; Kazuhiko Arima; Hiroaki Ida; Kiyoshi Migita; Tomoki Origuchi; Shuzo Tagashira; Fumio Nishikaku; Katsumi Eguchi
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells.
Biochemical and biophysical research communications 2003;312(2):397-404.